Citadel Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Sell |
|
|||||
|
2025
Q1 | $1.95M | Sell |
|
|||||
|
2024
Q4 | $12.5M | Buy |
|
|||||
|
2024
Q3 | $40.9M | Buy |
|
|||||
|
2024
Q2 | $18.8M | Sell |
|
|||||
|
2024
Q1 | $29.8M | Sell |
|
|||||
|
2023
Q4 | $30.2M | Buy |
|
|||||
|
2023
Q3 | $12.9M | Buy |
|
|||||
|
2023
Q2 | $13.2M | Sell |
|
|||||
|
2023
Q1 | $15.9M | Sell |
|
|||||
|
2022
Q4 | $19.5M | Sell |
|
|||||
|
2022
Q3 | $16.1M | Buy |
|
|||||
|
2022
Q2 | $9.79M | Buy |
|
|||||
|
2022
Q1 | $15.2M | Buy |
|
|||||
|
2021
Q4 | $16.2M | Buy |
|
|||||
|
2021
Q3 | $10.9M | Buy |
|
|||||
|
2021
Q2 | $5.01M | Sell |
|
|||||
|
2021
Q1 | $7.87M | Sell |
|
|||||
|
2020
Q4 | $19M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $5.9M | Buy |
|